Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans

The Journal of Clinical Investigation
A FlintJ J Holst

Abstract

We examined the effect of intravenously infused glucagon-like peptide 1 (GLP-1) on subjective appetite sensations after an energy-fixed breakfast, and on spontaneous energy intake at an ad libitum lunch. 20 young, healthy, normal-weight men participated in a placebo-controlled, randomized, blinded, crossover study. Infusion (GLP-1, 50 pmol/ kg.h or saline) was started simultaneously with initiation of the test meals. Visual analogue scales were used to assess appetite sensations throughout the experiment and the palatability of the test meals. Blood was sampled throughout the day for analysis of plasma hormone and substrate levels. After the energy-fixed breakfast, GLP-1 infusion enhanced satiety and fullness compared with placebo (treatment effect: P < 0.03). Furthermore, spontaneous energy intake at the ad libitum lunch was reduced by 12% by GLP-1 infusion compared with saline (P = 0.002). Plasma GLP-1, insulin, glucagon, and blood glucose profiles were affected significantly by the treatment (P < 0.002). In conclusion, the results show that GLP-1 enhanced satiety and reduced energy intake and thus may play a physiological regulatory role in controlling appetite and energy intake in humans.

References

Feb 1, 1988·International Journal of Sports Medicine·D L Costill
Apr 1, 1995·The British Journal of Nutrition·A RabenA Astrup
Jan 1, 1995·The Journal of Clinical Investigation·Z WangS R Bloom
Mar 23, 1994·Annals of the New York Academy of Sciences·G P Smith, J Gibbs
Apr 1, 1993·Digestive Diseases and Sciences·A WettergrenJ J Holst
Jul 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·D J DruckerP L Brubaker
Jan 1, 1997·Annual Review of Physiology·J J Holst
Jun 1, 1997·Scandinavian Journal of Gastroenterology·A WettergrenJ J Holst

❮ Previous
Next ❯

Citations

Apr 7, 2000·Diabetes/metabolism Research and Reviews·A J Scheen, P J Lefèbvre
Dec 7, 2002·Diabetes/metabolism Research and Reviews·Jens Juul Holst
Apr 6, 2006·Journal of Biosciences·Albert Goldbeter
Feb 22, 2011·Reviews in Endocrine & Metabolic Disorders·Jenny Tong, Darleen A Sandoval
Sep 27, 2007·Obesity Surgery·Edward E Mason
Apr 13, 2010·Obesity Surgery·Joanna PapailiouGeorge Zografos
Sep 29, 2005·Current Diabetes Reports·David A D'Alessio, Torsten P Vahl
Aug 11, 2006·Current Diabetes Reports·Juris J Meier, Michael A Nauck
Apr 29, 2010·Current Diabetes Reports·Mikkel Christensen, Filip K Knop
Sep 4, 2009·Applied Biochemistry and Biotechnology·Mingming GaoWenbing Yao
Dec 1, 2011·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Rupa Ahluwalia, Jiten Vora
May 15, 2002·European Journal of Pharmacology·Juris J MeierMichael A Nauck
Sep 17, 2002·European Journal of Pharmacology·Ulla RibelLotte Bjerre Knudsen
Jun 5, 2003·Physiology & Behavior·W L HallL M Morgan
Apr 24, 2001·Pharmacology & Therapeutics·J C ClaphamM Tadayyon
Jul 23, 2003·Trends in Pharmacological Sciences·TracyAnn Perry, Nigel H Greig
Jul 26, 2002·Regulatory Peptides·Juris J MeierBaptist Gallwitz
Jul 26, 2002·Regulatory Peptides·Ayhan BozkurtPer M Hellström
Feb 21, 2002·Progress in Neuro-psychopharmacology & Biological Psychiatry·Christian MöllerMarkus Heilig
Aug 21, 2003·Progress in Neurobiology·Mark J Millan
Feb 15, 2003·Domestic Animal Endocrinology·D G BurrinX Guan
Oct 31, 2000·Nutrition·C MacIntoshI M Chapman
Oct 31, 2000·Nutrition·G A Bray
Aug 26, 2000·Current Opinion in Chemical Biology·L H Van der Ploeg
Aug 22, 2009·Endocrinología y nutrición : órgano de la Sociedad Española de Endocrinología y Nutrición·Mayte Alvarez CrespoFederico Mallo Ferrer
Sep 21, 2000·The Proceedings of the Nutrition Society·G A Bray
Mar 9, 2007·The Proceedings of the Nutrition Society·Miguel LópezCarlos Diéguez
Sep 26, 2012·International Journal of Technology Assessment in Health Care·Lan GaoShu-Chuen Li
Nov 24, 2012·Nutrition Research Reviews·Andoni LanchaJavier Gómez-Ambrosi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.